000169387 001__ 169387
000169387 005__ 20240229133650.0
000169387 0247_ $$2doi$$a10.3238/arztebl.m2021.0111
000169387 0247_ $$2pmid$$apmid:34180790
000169387 0247_ $$2altmetric$$aaltmetric:100883984
000169387 037__ $$aDKFZ-2021-01461
000169387 041__ $$aEnglish
000169387 082__ $$a610
000169387 1001_ $$0P:(DE-HGF)0$$aCardoso, Rafael$$b0$$eFirst author
000169387 245__ $$aIncidence and Mortality of Proximal and Distal Colorectal Cancer in Germany.
000169387 260__ $$aKöln$$bDt. Ärzte-Verl.$$c2021
000169387 3367_ $$2DRIVER$$aarticle
000169387 3367_ $$2DataCite$$aOutput Types/Journal article
000169387 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1637159445_22468
000169387 3367_ $$2BibTeX$$aARTICLE
000169387 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000169387 3367_ $$00$$2EndNote$$aJournal Article
000169387 500__ $$a#EA:C120#LA:C070#
000169387 520__ $$aThe use of colonoscopy has increased and colorectal cancer (CRC) incidence has decreased after the introduction of screening colonoscopy in Germany. However, it remains unknown to what extent progress has been achieved in the prevention of cancer in the proximal colon, distal colon, and rectum.We analyzed trends in CRC incidence (2000-2016) and mortality (2000-2018) in Germany by sex, age, and tumor location.The age-standardized incidence of CRC declined by 22.4% (from 65.3 to 50.7 per 100 000) in men and by 25.5% (from 42.7 to 31.8 per 100 000) in women. CRC mortality declined by 35.8% (from 29.6 to 19.0 per 100 000) in men and by 40.5% (19.0 to 11.3 per 100 000) in women. Despite demographic changes, the annual numbers of CRC cases and deaths still decreased from about 60 400 to 58 300 and from around 28 700 to 24 200, respectively. The decline in incidence was greatest in groups aged ≥ 55 years. While the incidence of cancer in the distal colon and rectum decreased by 34.5% and 26.2%, respectively, in men and by 41.0% and 27.9% in women, the incidence of proximal colon cancer remained stable in men and decreased by only 7.0% in women. However, a major shift towards earlier stages was observed for the proximal cancers.The results support the assumption that the increased use of colo - noscopy has contributed to substantial reductions in the incidence of distal CRC incidence and the mortality from cancers in the entire colon and rectum.
000169387 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000169387 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
000169387 7001_ $$0P:(DE-He78)e71d98af5fac4f81eb58e74b7b3095c2$$aZhu, Anna$$b1
000169387 7001_ $$0P:(DE-He78)0311ebf3415e41860b4e2c56fbae6919$$aGuo, Feng$$b2
000169387 7001_ $$0P:(DE-He78)c465139c8b95a919efed7d35ca83ca80$$aHeisser, Thomas$$b3
000169387 7001_ $$0P:(DE-He78)6c5d058b7552d071a7fa4c5e943fff0f$$aHoffmeister, Michael$$b4
000169387 7001_ $$0P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aBrenner, Hermann$$b5$$eLast author
000169387 773__ $$0PERI:(DE-600)2406159-1$$a10.3238/arztebl.m2021.0111$$gVol. 118, no. 16$$n16$$p281-287$$tDeutsches Ärzteblatt international$$v118$$x1866-0452$$y2021
000169387 909CO $$ooai:inrepo02.dkfz.de:169387$$pVDB
000169387 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000169387 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)e71d98af5fac4f81eb58e74b7b3095c2$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000169387 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)0311ebf3415e41860b4e2c56fbae6919$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000169387 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)c465139c8b95a919efed7d35ca83ca80$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000169387 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)6c5d058b7552d071a7fa4c5e943fff0f$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000169387 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000169387 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000169387 9130_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000169387 9141_ $$y2021
000169387 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bDTSCH ARZTEBL INT : 2019$$d2021-01-27
000169387 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2021-01-27
000169387 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2021-01-27
000169387 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2021-01-27
000169387 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2021-01-27
000169387 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-01-27
000169387 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-01-27
000169387 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2021-01-27
000169387 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2021-01-27
000169387 9201_ $$0I:(DE-He78)C120-20160331$$kC120$$lPräventive Onkologie$$x0
000169387 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x1
000169387 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x2
000169387 980__ $$ajournal
000169387 980__ $$aVDB
000169387 980__ $$aI:(DE-He78)C120-20160331
000169387 980__ $$aI:(DE-He78)C070-20160331
000169387 980__ $$aI:(DE-He78)HD01-20160331
000169387 980__ $$aUNRESTRICTED